Client Spotlight

BD

In 2024, BD strengthened its position as a global leader in medical technology with the creation of its Advanced Patient Monitoring (APM) segment. This expansion was the result of BD’s acquisition of the Critical Care business unit of Edwards Lifesciences. We’re proud to have been selected to continue our work and transition our efforts from Edwards to BD.

BD
Client
BD
Client Since
2024
Website
bd.com

Advancing the world of health

Alluvia is currently supporting BD’s Advanced Patient Monitoring (APM) segment as they fulfill the company’s broader mission of advancing medical discovery and improving care delivery. Our involvement came at an interesting time in BD’s rich history. The company had just acquired the Critical Care business unit of Edwards Lifesciences to form the APM segment, with several new products launching at the same time.

We have partnered on launch campaigns for HemoSphere Alta™ Monitor and new AI-enabled sensor technologies—Swan-Ganz IQ™ Catheter and ForeSight IQ™ Sensor—to give clinicians predictive solutions that support critical clinical decisions. Our efforts included digital advertising, conference graphics, product campaigns, presentations, and more. We look forward to continuing this partnership and furthering BD’s work to enhance the safety and efficiency of care delivery for clinicians, empower laboratory scientists to detect disease with precision, and support researchers in advancing the next generation of diagnostics and therapeutics.

Other projects we have collaborated with BD on:
Social media graphics
Digital ads
Print ads
Product campaigns
Conference graphics and videos
Logos
Presentations
Email newsletters
Product videos